Stock A182400 NKMAX CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NKMAX CO., Ltd.

Equities

A182400

KR7182400002

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 24/03/2024 GMT 		5-day change 1st Jan Change
2,020 KRW +9.54% Intraday chart for NKMAX CO., Ltd. -.--% -67.58%
05-16 NKMAX CO., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-17 NKMAX CO., Ltd. cancelled the transaction announced on October 20, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NKMAX CO., LTD. Stock NKMAX CO., Ltd.
 125M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 109B
BIONTECH SE Stock BioNTech SE
 23.84B -
ARGENX SE Stock argenx SE
 22.42B -
GENMAB A/S Stock Genmab A/S
 17.5B
  1. Stock Market
  2. Equities
  3. A182400 Stock
  4. Charts NKMAX CO., Ltd.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW